About Index Trending news
Analyze
Pricing
miRagen Therapeutics

miRagen Therapeutics

Work at miRagen Therapeutics? Add yourself to this profile

miRagen Therapeutics

miRagen is a clinical stage biopharmaceutical company developing innovative microRNA-targeting therapies to improve human health.
Edit Profile
More info

Elsewhere

Also headquartered in Boulder

Techstars Techstars Ello Ello Startup Week Startup Week Foundry Group Foundry Group Occipital Occipital Deis Deis Revolv Revolv Brad Feld Brad Feld SolidFire SolidFire LogRhythm LogRhythm

Companies in the same industry

Clearside BioMedical, Inc. Clearside BioMedical, Inc. Neuronetics, Inc. Neuronetics, Inc. Theranica Theranica BD BD Daktari Diagnostics Daktari Diagnostics AutoGenomics AutoGenomics PharmaVOICE PharmaVOICE Black Diamond Ventures Black Diamond Ventures IRX Therapeutics, Inc. IRX Therapeutics, Inc. Nuo Therapeutics Nuo Therapeutics

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 4
Add info
01 Nov 2016
$40,000,000
Venture capital (Series D)
Atlas Venture, MP Healthcare Venture Management, Fidelity Management and Research Company, +4

Miragen racks up $40 mln, will merge with Signal Genetics

PE Hub
18 Feb 2015
$8,500,000
Venture capital (Series C)
Atlas Venture, Boulder Ventures, Broadview Ventures, +2
03 Jun 2009
$4,000,000
Venture capital (Series B)
Boulder Ventures, Broadview Ventures, Amgen, +1
19 May 2008
$8,000,000
Venture capital (Series A)
Atlas Venture, Boulder Ventures